ArticleNeuroImage2026
Automated detection of cerebral microbleeds on ex-vivo MRI scans of community-based older adults.
Article in NeuroImage, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cerebral microbleeds (CMBs) are small hemosiderin deposits visible on T2*-weighted MRI that have been associated with cerebrovascular pathology, cognitive decline, and increased stroke risk. While CMBs have been studied extensively in living populations, their relationship to neuropathology assessed at autopsy remains incompletely understood. Large-scale MRI-pathology studies are needed to clarify these associations, but manual annotation of CMBs on ex-vivo MRI is time-consuming and labor-intensive, creating a critical bottleneck. Automated detection of CMBs on ex-vivo MRI in community-based older adults is particularly challenging due to low CMB prevalence, abundant mimics (e.g. air bubbles), and limited training data. We present the first comprehensive automated detection algorithm for CMBs on ex-vivo T2*-weighted MRI from community-based older adults. Our approach combines a novel multi-echo synthesis algorithm with self-supervised pretraining using fuzzy segmentation and confidence-aware learning to address data scarcity and class imbalance. The method successfully captures 90% of definite CMBs (unambiguous hypointensities clearly within brain tissue) and 83% of all CMBs (definite and possible CMBs combined) at 15 false positives per scan in a dataset of 287 community-based older adults. This represents a 46% improvement in average precision over the baseline approach using only real data and establishes a benchmark for this challenging detection problem. The proposed system enables partially automated annotation workflows that reduce manual review burden by 5 to 20-fold compared to feature-based approaches, making large-scale MRI and pathology studies feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.